Year |
Citation |
Score |
2013 |
Zeng L, Bai M, Mittal AK, El-Jouni W, Zhou J, Cohen DM, Zhou MI, Cohen HT. Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma. Cancer Research. 73: 5371-80. PMID 23824745 DOI: 10.1158/0008-5472.CAN-12-4707 |
0.378 |
|
2012 |
Foy RL, Chitalia VC, Panchenko MV, Zeng L, Lopez D, Lee JW, Rana SV, Boletta A, Qian F, Tsiokas L, Piontek KB, Germino GG, Zhou MI, Cohen HT. Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1. Human Molecular Genetics. 21: 5456-71. PMID 23001567 DOI: 10.1093/Hmg/Dds391 |
0.672 |
|
2008 |
Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI, Bharti A, Seldin DC, Lecker SH, Dominguez I, Cohen HT. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nature Cell Biology. 10: 1208-16. PMID 18806787 DOI: 10.1038/Ncb1781 |
0.656 |
|
2008 |
Foy RL, Song IY, Chitalia VC, Cohen HT, Saksouk N, Cayrou C, Vaziri C, Côté J, Panchenko MV. Role of Jade-1 in the histone acetyltransferase (HAT) HBO1 complex. The Journal of Biological Chemistry. 283: 28817-26. PMID 18684714 DOI: 10.1074/Jbc.M801407200 |
0.622 |
|
2005 |
Cohen HT, McGovern FJ. Renal-cell carcinoma. The New England Journal of Medicine. 353: 2477-90. PMID 16339096 DOI: 10.1056/NEJMra043172 |
0.317 |
|
2005 |
Zhou MI, Foy RL, Chitalia VC, Zhao J, Panchenko MV, Wang H, Cohen HT. Jade-1, a candidate renal tumor suppressor that promotes apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 102: 11035-40. PMID 16046545 DOI: 10.1073/Pnas.0500757102 |
0.662 |
|
2005 |
Xu H, Tian W, Lindsley JN, Oyama TT, Capasso JM, Rivard CJ, Cohen HT, Bagnasco SM, Anderson S, Cohen DM. EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo. American Journal of Physiology. Renal Physiology. 288: F855-66. PMID 15561974 DOI: 10.1152/ajprenal.00347.2004 |
0.335 |
|
2004 |
Panchenko MV, Zhou MI, Cohen HT. von Hippel-Lindau partner Jade-1 is a transcriptional co-activator associated with histone acetyltransferase activity. The Journal of Biological Chemistry. 279: 56032-41. PMID 15502158 DOI: 10.1074/jbc.M410487200 |
0.386 |
|
2004 |
Zhou MI, Wang H, Foy RL, Ross JJ, Cohen HT. Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent. Cancer Research. 64: 1278-86. PMID 14973063 DOI: 10.1158/0008-5472.Can-03-0884 |
0.719 |
|
2003 |
Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, Christman MF. Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. Bmc Cancer. 3: 31. PMID 14641932 DOI: 10.1186/1471-2407-3-31 |
0.327 |
|
2002 |
Zhou MI, Wang H, Ross JJ, Kuzmin I, Xu C, Cohen HT. The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1. The Journal of Biological Chemistry. 277: 39887-98. PMID 12169691 DOI: 10.1074/jbc.M205040200 |
0.454 |
|
Show low-probability matches. |